Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-13

FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (NorthStar Rx LLC)

View source ↗

Summary

The FDA approved a supplemental application for a generic fixed-dose combination of losartan potassium and hydrochlorothiazide by NorthStar Rx LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan potassium and hydrochlorothiazide (losartan potassium and hydrochlorothiazide)

Snippet

SUPPL AP for LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE)